1. Bennett A, Charlier EN, McDonald AM, Simpson JS, Stamford IF, Zebro T. Prostaglandins and breast cancer. Lancet. 1977;2:624–6.
2. Bennett A, Berstock DA, Raja B, Stamford IF. Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancer. Br J Pharmacol. 1979;66:451–6.
3. Rolland PH, Martin PM, Jacquemier J, Rollnad AM, Toga M. Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst. 1980;64:1061–70.
4. Lucci A, Krishnamurthy S, Singh B, Bedrosian I, Meric-Bernstam F, Reuben J, et al. Cyclooxygenase-2 expression in primary breast cancer predicts dissemination of cancer cells to the bone marrow. Breast Cancer Res Treat. 2009;117:61–8.
5. Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002;62:632–5.